John M Leonard has sold stock and made no open-market buys since Sep 2016

President and CEO at Intellia Therapeutics, Inc., and 2 other companies

SEC CIK 0001563584 · Filings on SEC.gov ↗

$0Bought

$57.1MSold

NoneLast buy

Companies

Every filing

20 filings since Sep 2016, newest first

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$287K−1.9%Aug 24

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$314K−3.0%Jan 7

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$836K−7.0%Dec 12

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$566K−2.0%Jan 5

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$248K−1.0%Jan 6

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$280KMar 4

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$19.5M−13.0%Sep 1

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$4.1M−3.0%Aug 25

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$3.4M−3.0%Aug 20

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$3.2M−5.0%Apr 2

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$3.7M−7.0%Feb 9

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$12.0M−21.0%Feb 3

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$349K−1.0%Jan 5

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$1.4M−6.0%Nov 27

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$1.8M−9.0%Nov 25

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$680K−4.0%Nov 18

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$1.3M−9.0%Nov 6

NTLASell

Intellia Therapeutics, Inc.

President and CEO

$109K−1.0%Oct 9

IQVSell

Iqvia Holdings Inc.

Director

$3.1M−71.0%Dec 26

CMRXSell

Chimerix Inc

Director

$25K−100.0%Sep 16

Filings come from SEC EDGAR. Not investment advice.